The core activity of Canexis Pharma AG is the provision of services in the pharmaceutical industry, including the development, manufacture and quality assurance of pharmaceutical products. The company also offers services to non-pharma customers, but the main focus is on the pharmaceutical industry.
AI-generated
Offering
Products & services
Industry:Pharmaceutical Industry
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Manufacture of active pharmaceutical ingredients and non-finished medicinal products from cannabis; refinement of the cannabis plant into extracts, pure active substances and other cannabis medicinal products in line with EU/PIC/S-GMP and pharmacopeias.
Cannabis products for non-medical purposes
Extracts, distillates, isolates and standardised extracts with cannabidiol, cannabigerol, cannabinol and cannabichromene; also includes Cannabis sativa L. flowers with different THC contents.
Analytics
Cannabis testing according to relevant pharmacopeias, internal analysis for quality control, and support for incoming goods inspection, process control and release.
Consulting
Technical consulting and support in product development in the field of medical cannabis; solutions and non-binding advice for third parties.
Training
Training in the field of medical cannabis and GMP; knowledge transfer on processes, quality and regulatory requirements.